Padua BJ, Padua GJ, Anaya C, Galicia AJV, Fuentes LBC, Méndez LS

Language: Spanish
References: 10
Page: 68-72
PDF size: 1503.00 Kb.

ABSTRACT

During the SARS-CoV-2 Pandemic, a clinical case of a 43-year-old young man is presented, who after six days of attending a concert in Mexico City developed an infectious of the upper respiratory tract that evolved to a pneumonia with severe acute respiratory distress syndrome (ARDS), confirming SARS CoV2 infection and bacterial superinfection with resistant methicillin Staphylococcus aureus, requiring invasive ventilatory assistance and care in the Intensive Care Unit of the Hospital Bité Medica, Mexico City by an interdisciplinary group. The patient improved with hydroxychloroquine and lopinavir/ritonavir, systemic steroid, linezolid, ventilatory strategies for pulmonary protection, and general critical care without developing failure of other organs or systems.

REFERENCES

1. Na Zhu, Dingyu Zhang, Wenling Wang, Xingwang Li, Bo Yang, Jingdong Song, Xiang Zhao, Baoying Huang, et al. A novel coronavirus from patients with pneumonia in China 2019. N Engl J Med. 2020;382:727-733. doi: 10.1056/NEJMoa2001017.

2. Habibzadeh P, Stoneman EK. The novel coronavirus: a bird’s eye view. Int J Occup Environ Med. 2020;11:65-71.

3. Muhammad AS. COVID-19 infection: origin, transmisión, and characteristics of human coronaviruses. J Advanced Research. 2020;24:91-98.

4. Gattinoni L. Preliminary observation on the ventilatory management of ICU Covid-19 patients. doi: 10.15171/iojem.2020.1921 (letter unpublished). www.sfar.org. Consultado el 24 marzo 2020.

5. Chaomin Wu, Xiaoyan Chen, Yanping Cai, Jia’an Xia, Xing Zhou, Sha Xu, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumoniain Wuhan, China. JAMA Internal Medicine. 2020. doi: 10.1001/jamaintermed.2020.0994.

6. Ye Yi, Lagniton PN, Sen Ye, Enqin Li, Ren-He Xu. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020;16(10):1753-1766. doi: 10.7150/ijbs.45134.

7. Matthay MA, Aldrich JM, Gotts JE. Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir Med. 2020. doi: org/10.1016/S2213-2600(20)30127-2.

8. Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign; guidelines on the management of critical ill adults with coronavirus disease 2019 COVID-19. Intensive Care Med. 2020. doi: 10.1007/s00134-020-06022-5.

9. Nicastri E, Petrosillo N, Ascoli BT, Lepore L, Mondi A, Palmieri F. National Institute for the Infectious Diseases “L Spallanazi”, IRCCS. Recomendations for the COVID-19 clinical management. Infectious Disease Reports. 2020;12:8543.

10. Huilan Zhang, Peng Zhou, Yanqiu Wei, Huihui Yue, Yi Wang, Ming Hu, et al. Histopathologic changes and SARS- CoV-2 immunostaining in the lung of a patient With COVID-19. Ann Intern Med. 2020. doi: 10.7326/M20-0533. Published at www.annals.org on 12 March 2020.